findmyKOL

Michael Kolber, MD

Basic profile

University of Miami

ORCIDNPI
RegionMiami, FL · SoutheastSpecialtyClinical & Laboratory ImmunologyFocusRheumatology/Immunology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Michael Kolber is a Rheumatology/Immunology physician affiliated with University of Miami. OpenAlex indexes 99 publications with 3,077 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
99publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,077citations

Total citations across indexed works.

28h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1611 NW 12th Ave
Box 016960 M851
Miami, FL 331361005

Telephone

305-243-4791

Registry record last updated 15 Nov 2011.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    76.5%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor37.1%
    Juluca53%Tivicay47%
    Part D<11 patients
    Protease Inhibitor23.5%
    Prezcobix100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    23.5%
    Beta blocker14.4%
    Carvedilol100%
    Part D<11 patients
    Statin9.1%
    Atorvastatin Calcium100%
    Part D<11 patients
Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”